These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 18270770)

  • 21. A Preclinical Animal Study of Combined Intragastric Balloon and Duodenal-Jejunal Bypass Liner for Obesity and Metabolic Disease.
    Ghoz H; Jaruvongvanich V; Matar R; Beran A; Maselli DB; Storm AC; Abu Dayyeh BK
    Clin Transl Gastroenterol; 2020 Sep; 11(9):e00234. PubMed ID: 33094961
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peroral transgastric endoscopic procedures in pigs: feasibility, survival, questionings, and pitfalls.
    Simopoulos C; Kouklakis G; Zezos P; Ypsilantis P; Botaitis S; Tsalikidis C; Pitiakoudis M
    Surg Endosc; 2009 Feb; 23(2):394-402. PubMed ID: 18437468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Duodenal-jejunal bypass attenuates progressive failure of pancreatic islets in streptozotocin-induced diabetic rats.
    Wang T; Zhang P; Zhang X; Cao T; Zheng C; Yu B
    Surg Obes Relat Dis; 2017 Feb; 13(2):250-260. PubMed ID: 27865809
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design of the Weight-loss Endoscopy Trial (WET): a multi-center, randomized, controlled trial comparing weight loss in endoscopically implanted duodenal-jejunal bypass liners vs. intragastric balloons vs. a sham procedure.
    Hollenbach M; Prettin C; Gundling F; Schepp W; Seufert J; Stein J; Rösch T; Aberle J; Feisthammel J; Petroff D; Hoffmeister A
    BMC Gastroenterol; 2018 Jul; 18(1):118. PubMed ID: 30021518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endoscopic Therapeutic Option for Weight Loss and Control of Type 2 Diabetes: the Duodenal-Jejunal Bypass Liner.
    de Moura EG; Orso IR; Martins BC; Lopes GS
    Surg Technol Int; 2015 May; 26():115-9. PubMed ID: 26054998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preserving Duodenal-Jejunal (Foregut) Transit Does Not Impair Glucose Tolerance and Diabetes Remission Following Gastric Bypass in Type 2 Diabetes Sprague-Dawley Rat Model.
    Dolo PR; Yao L; Li C; Zhu X; Shi L; Widjaja J
    Obes Surg; 2018 May; 28(5):1313-1320. PubMed ID: 29098544
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiographic appearance of endoscopic duodenal-jejunal bypass liner for treatment of obesity and type 2 diabetes.
    Levine A; Ramos A; Escalona A; Rodriguez L; Greve JW; Janssen I; Rothstein R; Nepomnayshy D; Gersin KS; Melanson D; Lamport R; Fishman E; Malomo K; Kaplan LM; Neto MG
    Surg Obes Relat Dis; 2009; 5(3):371-4. PubMed ID: 19460677
    [No Abstract]   [Full Text] [Related]  

  • 28. Duodenal-jejunal bypass with sleeve gastrectomy versus the sleeve gastrectomy procedure alone: the role of duodenal exclusion.
    Lee WJ; Almulaifi AM; Tsou JJ; Ser KH; Lee YC; Chen SC
    Surg Obes Relat Dis; 2015; 11(4):765-70. PubMed ID: 25813754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Establishing a successful rat model of duodenal- jejunal bypass: A detailed guide.
    Akalestou E; Genser L; Villa F; Christakis I; Chokshi S; Williams R; Rubino F
    Lab Anim; 2019 Aug; 53(4):362-371. PubMed ID: 30227760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implantable endoscopic gastric bypass - device and experimental procedure.
    Schurr MO; Ho CN; Rieber F; Fleisch C; Coscarella G; Tognoni V; Di Lorenzo N
    Minim Invasive Ther Allied Technol; 2009; 18(5):273-9. PubMed ID: 19707933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is reimplantation of the duodenal-jejunal bypass liner feasible?
    Koehestanie P; Betzel B; Aarts EO; Janssen IM; Wahab P; Berends FJ
    Surg Obes Relat Dis; 2015; 11(5):1099-104. PubMed ID: 25979208
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic improvements in obese type 2 diabetes subjects implanted for 1 year with an endoscopically deployed duodenal-jejunal bypass liner.
    de Moura EG; Martins BC; Lopes GS; Orso IR; de Oliveira SL; Galvão Neto MP; Santo MA; Sakai P; Ramos AC; Garrido Júnior AB; Mancini MC; Halpern A; Cecconello I
    Diabetes Technol Ther; 2012 Feb; 14(2):183-9. PubMed ID: 21932999
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of Sleeve Gastrectomy with Duodenal-Jejunal Bypass for the Treatment of Obese Severe Diabetes Patients in Japan: a Retrospective Multicenter Study.
    Naitoh T; Kasama K; Seki Y; Ohta M; Oshiro T; Sasaki A; Miyazaki Y; Yamaguchi T; Hayashi H; Imoto H; Tanaka N; Unno M
    Obes Surg; 2018 Feb; 28(2):497-505. PubMed ID: 28795271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The duodenal-jejunal bypass sleeve (EndoBarrier Gastrointestinal Liner) for weight loss and treatment of type 2 diabetes.
    Patel SR; Hakim D; Mason J; Hakim N
    Surg Obes Relat Dis; 2013; 9(3):482-4. PubMed ID: 23452926
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loop Duodenojejunal Bypass with Sleeve Gastrectomy: Comparative Study with Roux-en-Y Gastric Bypass in Type 2 Diabetic Patients with a BMI <35 kg/m(2), First Year Results.
    Huang CK; Tai CM; Chang PC; Malapan K; Tsai CC; Yolsuriyanwong K
    Obes Surg; 2016 Oct; 26(10):2291-301. PubMed ID: 26935711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New Anchoring Mechanism and Design of an Endoluminal Duodeno-Jejunal Bypass Liner for Treatment of Obesity: a Pilot Animal Trial.
    Frydenberg Am HB; Suturin VM; Truong H; Ryan A; Soutorine M
    Obes Surg; 2019 Sep; 29(9):3081-3085. PubMed ID: 31127497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety experience with the duodenal-jejunal bypass liner: an endoscopic treatment for diabetes and obesity.
    Betzel B; Koehestanie P; Aarts EO; Dogan K; Homan J; Janssen IM; Wahab PJ; Groenen MJ; Berends FJ
    Gastrointest Endosc; 2015 Nov; 82(5):845-52. PubMed ID: 25952090
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Laparoscopic Conversion from Single Anastomosis Duodeno-Jejunal Bypass with Sleeve Gastrectomy (SADJ-S) to Roux-en-Y Gastric Bypass (GBP): Improving Unsatisfactory Outcomes.
    Vilallonga R; Curbelo Y; Sanchez-Cordero S; Roriz-Silva R; Bademci R; Torres AJ
    Obes Surg; 2020 Jan; 30(1):365-368. PubMed ID: 31183786
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of the Duodenal-Jejunal Bypass Liner on Glycemic Control in Patients With Type 2 Diabetes With Obesity: A Meta-analysis With Secondary Analysis on Weight Loss and Hormonal Changes.
    Jirapinyo P; Haas AV; Thompson CC
    Diabetes Care; 2018 May; 41(5):1106-1115. PubMed ID: 29678867
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Minimally invasive entero-enteral dual-path bypass using self-assembling magnets.
    Ryou M; Aihara H; Thompson CC
    Surg Endosc; 2016 Oct; 30(10):4533-8. PubMed ID: 26895911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.